On 2025-08-07, Crinetics Pharmaceuticals, Inc. (CRNX) announced earnings per share of $-1.23 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-1.13.
The next expected annoucement date for quarterly earnings is 2025-11-06, with an average estimated earnings per share of $-1.27 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-07 | 2025-06-30 | $-1.13 | $-1.23 |
| 2025-05-08 | 2025-03-31 | $-0.99 | $-1.04 |
| 2025-02-27 | 2024-12-31 | $-0.92 | $-0.88 |
| 2024-11-12 | 2024-09-30 | $-0.91 | $-0.96 |
| 2024-08-08 | 2024-06-30 | $-0.86 | $-0.94 |
| 2024-05-09 | 2024-03-31 | $-0.84 | $-0.93 |
| 2024-02-28 | 2023-12-31 | $-0.89 | $-0.90 |
| 2023-11-07 | 2023-09-30 | $-0.89 | $-1.01 |
| 2023-08-08 | 2023-06-30 | $-0.85 | $-0.94 |
| 2023-05-04 | 2023-03-31 | $-0.82 | $-0.85 |
| 2023-02-28 | 2022-12-31 | $-0.82 | $-0.84 |
| 2022-11-14 | 2022-09-30 | $-0.78 | $-0.78 |
| 2022-08-12 | 2022-06-30 | $-0.62 | $-0.81 |
| 2022-05-12 | 2022-03-31 | $-0.56 | $-0.73 |
| 2022-03-30 | 2021-12-31 | $-0.57 | $-0.68 |
| 2021-11-05 | 2021-09-30 | $-0.70 | $-0.73 |
| 2021-08-10 | 2021-06-30 | $-0.60 | $-0.70 |
| 2021-05-06 | 2021-03-31 | $-0.65 | $-0.69 |
| 2021-03-30 | 2020-12-31 | $-0.58 | $-0.66 |
| 2020-11-06 | 2020-09-30 | $-0.52 | $-0.56 |
| 2020-08-07 | 2020-06-30 | $-0.52 | $-0.53 |
| 2020-05-08 | 2020-03-31 | $-0.63 | $-0.71 |
| 2020-03-09 | 2019-12-31 | $-0.67 | $-0.60 |
| 2019-11-12 | 2019-09-30 | $-0.54 | $-0.60 |
| 2019-08-13 | 2019-06-30 | $-0.45 | $-0.51 |
| 2019-05-13 | 2019-03-31 | $-0.39 | $-0.37 |
| 2019-03-13 | 2018-12-31 | $-0.39 | $-0.35 |
| 2018-11-13 | 2018-09-30 | $-0.34 | $-0.38 |
| 2018-08-30 | 2018-06-30 | $-0.29 | $-2.41 |